Gleevec
Active Ingredient(s): Imatinib, STI-571FDA Approved: * May 10, 2001
Pharm Company: * NOVARTIS
Category: Cancer
Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral chemotherapy medication used to treat cancer.[2] Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodys... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.21 Discussions
Dosage List
Related Brands
Drugs with the same active ingredientsPopular Topics
I have had similar side effects to taking Gleevec and Meloxicam. What compounds are the same in these two meds that I am...
3 REPLIESDoes Gleevec work for acute eczema and acute dry skin? ## I don't have any information on this, but I can tell you t...
2 REPLIESCan anyone else tell me how long gone after starting gleevec gleevec will side effects show hp? ## It can vary from pers...
2 REPLIESDoes taking medical marijuana adversely affect the treatment? I am taking an 800mg dose of Gleevec a day and have had my...
1 REPLYI take Gleevec 400mg for CML. After a short period of time I experience some very rough side effects. Bones hurt, eyes a...
1 REPLYI have a GIST Tumor and have started taking Gleevec, 800MGS per day. I know there is no cure but I am curious about how ...
1 REPLYMy seven pound dog swallowed a gleevec 100 tablet. I induced vomiting with peroxide but not sure if it came up as she ha...
I've been on Gleevec for about 6 years being treated for HES with no side effects once regulated. Just over the past...
1 REPLYi'm african american taking gleevec. This skin coloration started about 2 months ago. I's not listed as side eff...
3 REPLIESI took gleevec for 4 months before surgery. I had a 'gist' cancer tumor. Then stopped taking it. How long does i...